These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35568804)

  • 1. Predictors of very early stroke recurrence in the POINT trial population.
    Bourand N; Brorson JR
    BMC Neurol; 2022 May; 22(1):177. PubMed ID: 35568804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Systolic Blood Pressure, Use of Aspirin and Clopidogrel, and Stroke Recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial.
    de Havenon A; Johnston SC; Easton JD; Kim AS; Sheth KN; Lansberg M; Tirschwell D; Mistry E; Yaghi S
    JAMA Netw Open; 2021 Jun; 4(6):e2112551. PubMed ID: 34086033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
    JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial.
    Kamel H; Zhang C; Kleindorfer DO; Levitan EB; Howard VJ; Howard G; Soliman EZ; Johnston SC
    JAMA Neurol; 2020 May; 77(5):601-605. PubMed ID: 32091536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
    Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC
    JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial.
    Mac Grory B; Piccini JP; Yaghi S; Poli S; De Havenon A; Rostanski SK; Weiss M; Xian Y; Johnston SC; Feng W
    J Am Heart Assoc; 2022 Feb; 11(3):e023223. PubMed ID: 35043692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipsilateral Nonstenotic Carotid Disease in Minor Ischemic Stroke: an Exploratory Analysis of The POINT Randomized Clinical Trial.
    Bulwa Z; Saleh Velez FG; Brorson JR; Pinto CB
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105115. PubMed ID: 33066893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial.
    Cucchiara B; Elm J; Easton JD; Coutts SB; Willey JZ; Biros MH; Ross MA; Johnston SC
    Stroke; 2020 Mar; 51(3):792-799. PubMed ID: 32078486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
    Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
    Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    Johnston SC; Easton JD; Farrant M; Barsan W; Conwit RA; Elm JJ; Kim AS; Lindblad AS; Palesch YY;
    N Engl J Med; 2018 Jul; 379(3):215-225. PubMed ID: 29766750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.
    Jing J; Meng X; Zhao X; Liu L; Wang A; Pan Y; Li H; Wang D; Johnston SC; Wang Y; Wang Y
    JAMA Neurol; 2018 Jun; 75(6):711-719. PubMed ID: 29582084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
    Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y;
    JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.
    Li J; Wang Y; Li H; Zuo Z; Lin J; Wang A; Zhao X; Liu L; Wang Y;
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):839-846. PubMed ID: 31941381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial.
    Wangqin R; Wang X; Wang Y; Xian Y; Zhao X; Liu L; Li H; Meng X; Wang Y
    Stroke Vasc Neurol; 2017 Dec; 2(4):176-183. PubMed ID: 29507777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Secondary Prevention in Transient Ischemic Attack (TIA) and Minor Stroke.
    Tse D; Hill MD; Coutts SB
    Curr Neurol Neurosci Rep; 2019 May; 19(6):34. PubMed ID: 31089960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin plus clopidogrel
    Ye MB; Chen YL; Wang Q; An J; Ye F; Jing P
    Scand Cardiovasc J; 2019 Aug; 53(4):169-175. PubMed ID: 31112048
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
    Tillman H; Johnston SC; Farrant M; Barsan W; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Easton JD
    JAMA Neurol; 2019 Jul; 76(7):774-782. PubMed ID: 31034032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.
    Johnston SC; Elm JJ; Easton JD; Farrant M; Barsan WG; Kim AS; Lindblad AS; Palesch YY; Zurita KG; Albers GW; Cucchiara BL; Kleindorfer DO; Lutsep HL; Pearson C; Sethi P; Vora N;
    Circulation; 2019 Aug; 140(8):658-664. PubMed ID: 31238700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke.
    De Matteis E; De Santis F; Ornello R; Censori B; Puglisi V; Vinciguerra L; Giossi A; Di Viesti P; Inchingolo V; Fratta GM; Diomedi M; Bagnato MR; Cenciarelli S; Bedetti C; Padiglioni C; Tassinari T; Saia V; Russo A; Petruzzellis M; Mezzapesa DM; Caccamo M; Rinaldi G; Bavaro A; Paciaroni M; Mosconi MG; Foschi M; Querzani P; Muscia F; Gallo Cassarino S; Candelaresi P; De Mase A; Guarino M; Cupini LM; Sanzaro E; Zini A; La Spada S; Palmieri C; Sepe FN; Beretta S; Paci C; Caggia EA; De Angelis MV; Bonanni L; Volpi G; Tassi R; Pistoia F; Scoditti U; Tonon A; Viticchi G; Ruzza G; Nencini P; Cavallini A; Toni D; Ricci S; Sacco S;
    Stroke; 2023 May; 54(5):1172-1181. PubMed ID: 36951052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.